Qi Cai

Dr. Qi Cai

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2017 in ACS Nano
Verified
Journal Article
Closed access
LTLaura Talamini
Laura Talamini
MVMartina Bruna Violatto
Martina Bruna Violatto
QCQi Cai
Qi Cai
Marco P. MonopoliMarco P. Monopoli
Marco P. Monopoli
KKKarsten Kantner
Karsten Kantner
Paolo BiginiPaolo Bigini
Paolo Bigini

15 August 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
QCQi Cai
Qi Cai
XLXiaoqing Li
Xiaoqing Li
HXHejian Xiong
Hejian Xiong
HFHanwen Fan
Hanwen Fan
XGXiaofei Gao
Xiaofei Gao
ZQZhenpeng Qin
Zhenpeng Qin
The treatment of glioblastoma has limited clinical progress over the past decade, partly due to the lack of effective drug delivery strategies across the blood-brain-tumor barrier. Moreover, discrepancies between preclinical and clinical outcomes demand a reliable translational platform that can precisely recapitulate the characteristics of human glioblastoma. Here we analyze the intratumoral blood-brain-tumor barrier heterogeneity in human glioblastoma and characterize two genetically engineered models in female mice that recapitulate two important glioma phenotypes, including the diffusely infiltrative tumor margin and angiogenic core. We show that pulsed laser excitation of vascular-targeted gold nanoparticles non-invasively and reversibly modulates the blood-brain-tumor barrier permeability (optoBBTB) and enhances the delivery of paclitaxel in these two models. The treatment reduces the tumor volume by 6 and 2.4-fold and prolongs the survival by 50% and 33%, respectively. Since paclitaxel does not penetrate the blood-brain-tumor barrier and is abandoned for glioblastoma treatment following its failure in early-phase clinical trials, our results raise the possibility of reevaluating a number of potent anticancer drugs by combining them with strategies to increase blood-brain-tumor barrier permeability. Our study reveals that optoBBTB significantly improves therapeutic delivery and has the potential to facilitate future drug evaluation for cancers in the central nervous system.

13 March 2017 in Nanoscale Horizons
Verified
Journal Article
Open access
PDF file
VCV. Castagnola
V. Castagnola
JCJennifer Cookman
Jennifer Cookman
JAJoão de Araújo
João de Araújo
Ester PoloEster Polo
Ester Polo
QCQi Cai
Qi Cai
KDK. A. Dawson
K. A. Dawson
The range of possible nanostructures is so large and continuously growing, that collating and unifying the knowledge connected to them, including their biological activity, is a major challenge.

4 February 2022 in Nanoscale Horizons
Verified
Journal Article
Open access
PDF file
QCQi Cai
Qi Cai
VCValentina Castagnola
Valentina Castagnola
Luca BoselliLuca Boselli
Luca Boselli
AMAlirio Moura
Alirio Moura
HLHender Lopez
Hender Lopez
KDKenneth A. Dawson
Kenneth A. Dawson
Automatized approaches for nanoparticle synthesis and characterization represent a great asset to their applicability in the biomedical field by improving reproducibility and standardization, which will help meet the regulatory authorities' criteria.

19 January 2017 in Nanoscale
Verified
Journal Article
Open access
PDF file
MPM. A. C. Potenza
M. A. C. Potenza
ŽKŽ. Krpetić
Ž. Krpetić
TST. Sanvito
T. Sanvito
QCQi Cai
Qi Cai
Marco P. MonopoliMarco P. Monopoli
Marco P. Monopoli
KDK. A. Dawson
K. A. Dawson
The shape and size of nanoparticles are important parameters affecting their biodistribution, bioactivity, and toxicity. The high-throughput characterisation of the nanoparticle shape in dispersion is a fundamental prerequisite for realistic in vitro and in vivo evaluation, however, with routinely available bench-top optical characterisation techniques, it remains a challenging task. Herein, we demonstrate the efficacy of a single particle extinction and scattering (SPES) technique for the in situ detection of the shape of nanoparticles in dispersion, applied to a small library of anisotropic gold particles, with a potential development for in-line detection. The use of SPES paves the way to the routine quantitative analysis of nanoparticles dispersed in biologically relevant fluids, which is of importance for the nanosafety assessment and any in vitro and in vivo administration of nanomaterials.

17 January 2023 in Nanoscale
Verified
Journal Article
Closed access
PDF file
XLXiaoqing Li
Xiaoqing Li
QCQi Cai
Qi Cai
BWBlake A. Wilson
Blake A. Wilson
HFHanwen Fan
Hanwen Fan
HDHarsh Dave
Harsh Dave
ZQZhenpeng Qin
Zhenpeng Qin
The blood–brain barrier (BBB) maintains an optimal environment for brain homeostasis but excludes most therapeutics from entering the brain. Strategies that reversibly increase BBB permeability are essential for treating brain diseases and are the focus of significant preclinical and translational interest. Picosecond laser excitation of tight junction-targeted gold nanoparticles (AuNPs) generates a nanoscale mechanical perturbation and induces a graded and reversible increase in BBB permeability (OptoBBB). Here we advanced this technique by showing that targeting endothelial glycoproteins leads to >10-fold higher targeting efficiency than targeting tight junctions both in vitro and in vivo. With both tight-junction and glycoprotein targeting, we demonstrate that OptoBBB is associated with a transient elevation and propagation of Ca2+, actin polymerization, and phosphorylation of ERK1/2 (extracellular signal-regulated protein kinase). These collectively activate the cytoskeleton resulting in increased paracellular permeability. The Ca2+ response involves internal Ca2+ depletion and Ca2+ influx with contributions from mechanosensitive ion channels (TRPV4, Piezo1). We provide insight into how the excitation of tight junction protein (JAM-A)-targeted and endothelial (glycocalyx)-targeted AuNPs leads to similar mechanobiological modulation of BBB permeability while targeting the glycocalyx significantly improves the nanoparticle accumulation in the brain. The results will be critical for guiding the future development of this technology for brain disease treatment.